Eli Lilly Aktie

Eli Lilly für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 858560 / ISIN: US5324571083

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
16.12.2019 13:00:57

Lilly To Include Dexcom's Technology Into Its Diabetes Management System

(RTTNews) - Eli Lilly and Company (LLY) has reached a global commercialization agreement to integrate DexCom, Inc. (DXCM) products into Lilly's personalized diabetes management system. Under the agreement, Lilly will use Dexcom's continuous glucose monitoring devices in both the pen- and pump-based platforms of the system being designed to help improve diabetes management.

Rick Doubleday, chief commercial officer of Dexcom, stated: "We're looking forward to expanding our collaboration with Lilly as we integrate our technology into their system and believe it will help reduce some of the complexity that can come from managing diabetes every day."

Analysen zu Eli Lillymehr Analysen

20.12.24 Eli Lilly Buy Jefferies & Company Inc.
31.10.24 Eli Lilly Buy Jefferies & Company Inc.
13.02.24 Eli Lilly Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DexCom Inc. 73,21 16,43% DexCom Inc.
Eli Lilly 684,10 -1,01% Eli Lilly